If surgery center leaders can identify and add an up-and-coming procedure to their list of approved procedures prior to their competitors doing such, they may be able to corner the market and profit ...

CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving greater utilization than the earlier Xi model.

Patients on GLP-1 receptor agonists should stop taking them prior to elective surgery due to concerns over increased risk for regurgitation and pulmonary aspiration of gastric contents while under ...